Yamo Pharmaceuticals Competitors and Similar CompaniesClear all
Yamo Pharmaceuticals's competitors and similar companies include PaxMedica, AdoRx Therapeutics and Treeway.
 Yamo Pharmaceuticals Yamo Pharmaceuticals is a company developing L1-79, a therapy that targets the core symptoms of autism. |  PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). |  AdoRx Therapeutics AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway. | ||
Founding Date | Founding Date N/A | Founding Date 2018 | Founding Date N/A | Founding Date 2012 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations HQ | Locations Tarrytown, US HQ | Locations Edinburgh, GB HQ | Locations Tilburg, NL HQ |
Employees | Employees 6 | Employees 2100% increase | Employees N/A | Employees 12 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 10m (about 8 years ago) | Latest funding round $ 55.8k (about 11 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 10m | Total funding raised $ 55.8k |
For sources of this data, please see the company profile
View Company Profiles
PaxMedica
HQ
Tarrytown, US
Employees
2
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View companyAdoRx Therapeutics
HQ
Edinburgh, GB
AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
View company